There’s lots in this. The first is, does Ontario need a rare disease strategy so that people who live with rare diseases gain access to new technology, new treatment faster? Absolutely, yes. Does the program in place, where CADTH, the federal government, decides if the medication is effective or not, then it gets negotiated—I can tell you that of all of the provinces in the system that we have now, Ontario is the slowest. It takes, on average, 10 months longer for Ontario to add a drug to their formulary than every other province, the three territories and the federal government. Could we do things better? Yes, absolutely. When every other province has added a drug in their formulary, don’t take 10 months to add it to Ontario’s formulary.

Yes, I have hope that, at some point, good sense will prevail.